Literature DB >> 2418494

Identification of a cell-surface glycoprotein mediating adhesion in human granulocytes.

M Patarroyo, P G Beatty, C N Serhan, C G Gahmberg.   

Abstract

Previous studies have shown that monoclonal antibody 60.3 reacting with a surface antigen common to human leukocytes inhibits phorbol ester-induced adhesion among blood mononuclear cells and precipitates from these cells three surface polypeptides with apparent molecular weights of 90,000, 130,000 and 160,000. Now we report that the same antibody, either as purified IgG or Fab fragments, also inhibits the extensive adhesion among granulocytes induced by phorbol ester. Inhibition of cell aggregation was not observed with monoclonal antibodies to C3b receptor, common leukocyte antigen T200, C3bi receptor, brain granulocyte-T lymphocyte antigen, IgG Fc receptor, class I transplantation antigen, or a granulocyte-specific antigen. Intercellular adhesion induced by either the chemotactic tripeptide N-formylmethionyl-leucyl-phenylalanine (FMLP) or the ionophore A23187 was also inhibited by antibody 60.3. However, this antibody did not affect phorbol ester-induced superoxide (O2-) generation or lysozyme release. Two major surface glycopolypeptides with apparent molecular weights of 92,000 and 155,000 were immunoprecipitated from granulocytes. Dissociation of the protein complexes obtained from blood mononuclear cells and granulocytes indicated the presence of the epitope on the 90,000-92,000 molecular-weight components. It is thus concluded that the smallest glycopolypeptides mediate adhesion in human granulocytes and mononuclear leukocytes.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2418494     DOI: 10.1111/j.1365-3083.1985.tb01924.x

Source DB:  PubMed          Journal:  Scand J Immunol        ISSN: 0300-9475            Impact factor:   3.487


  9 in total

1.  A monoclonal antibody inhibiting leucocyte adhesion blocks induction of IL-2 production but not IL-2 receptor expression.

Authors:  C Lindqvist; M Patarroyo; P G Beatty; H Wigzell
Journal:  Immunology       Date:  1987-04       Impact factor: 7.397

2.  Stimulation of neutrophil adhesion by antibodies recognizing CD15 (Le(X)) and CD15-expressing carcinoembryonic antigen-related glycoprotein NCA-160.

Authors:  S C Stocks; M A Kerr
Journal:  Biochem J       Date:  1992-11-15       Impact factor: 3.857

3.  Leukotriene B4-induced hyperadhesiveness of endothelial cells for neutrophils: relation to CD54.

Authors:  J E Palmblad; R Lerner
Journal:  Clin Exp Immunol       Date:  1992-11       Impact factor: 4.330

4.  Plasma membrane proteins from human normal and chronic myeloid leukemic granulocytes: identification and partial characterization of the concanavalin A-binding and detergent resistant proteins.

Authors:  S M Zingde; S H Advani; B P Gothoskar
Journal:  Blut       Date:  1987-08

Review 5.  Molecular genetics of human chromosome 21.

Authors:  P C Watkins; R E Tanzi; S V Cheng; J F Gusella
Journal:  J Med Genet       Date:  1987-05       Impact factor: 6.318

6.  Molecules mediating adhesion of T and B cells, monocytes and granulocytes to vascular endothelial cells.

Authors:  J Prieto; P G Beatty; E A Clark; M Patarroyo
Journal:  Immunology       Date:  1988-04       Impact factor: 7.397

7.  Tumor necrosis factor-induced degranulation in adherent human neutrophils is dependent on CD11b/CD18-integrin-triggered oscillations of cytosolic free Ca2+.

Authors:  J Richter; J Ng-Sikorski; I Olsson; T Andersson
Journal:  Proc Natl Acad Sci U S A       Date:  1990-12       Impact factor: 11.205

8.  Heparin is an adhesive ligand for the leukocyte integrin Mac-1 (CD11b/CD1).

Authors:  M S Diamond; R Alon; C A Parkos; M T Quinn; T A Springer
Journal:  J Cell Biol       Date:  1995-09       Impact factor: 10.539

9.  The I domain is a major recognition site on the leukocyte integrin Mac-1 (CD11b/CD18) for four distinct adhesion ligands.

Authors:  M S Diamond; J Garcia-Aguilar; J K Bickford; A L Corbi; T A Springer
Journal:  J Cell Biol       Date:  1993-02       Impact factor: 10.539

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.